Market Tracker

07/23 12:15pm ET
1.33
Real-Time Quote
 +0.03 / +2.31%
Today’s Change
1.25
Today|||52-Week Range
5.17
-19.39%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close1.30
Today’s open1.29
Day’s range1.28 - 1.42
Volume787,924
Average volume (3 months)488,670
Market cap$97.7M
Dividend yield--
Data as of 12:00pm ET, 07/23/2014

Growth & Valuation

Earnings growth (last year)-55.81%
Earnings growth (this year)+38.43%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.69

Competitors

 Today’s
change
Today’s
% change
AMBIAmbit Biosciences Co...+0.02+0.37%
PRANPrana Biotechnology ...-0.05-2.09%
ACSTAcasti Pharma Inc+0.09+9.45%
EVARLombard Medical Inc+0.02+0.32%
Data as of 12:00pm ET, 07/23/2014

Financials

Next reporting dateAugust 11, 2014
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$0.00
Annual profit (last year)-$42.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer, COO &
Director
Marc Steven Hanover
CFO, CAO, Accounting Director &
Controller
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts